Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 27 04:00PM ET
24.60
Dollar change
+0.56
Percentage change
2.33
%
IndexRUT P/E- EPS (ttm)-3.59 Insider Own53.18% Shs Outstand55.64M Perf Week8.18%
Market Cap2.00B Forward P/E- EPS next Y-3.14 Insider Trans-1.85% Shs Float37.97M Perf Month16.26%
Income-208.13M PEG- EPS next Q-0.92 Inst Own52.75% Short Float19.09% Perf Quarter122.62%
Sales0.00M P/S- EPS this Y-17.17% Inst Trans-3.55% Short Ratio3.90 Perf Half Y106.90%
Book/sh2.48 P/B9.92 EPS next Y17.15% ROA-82.44% Short Interest7.25M Perf Year112.07%
Cash/sh1.95 P/C12.64 EPS next 5Y- ROE-103.60% 52W Range6.40 - 25.50 Perf YTD84.96%
Dividend Est.- P/FCF- EPS past 5Y-135.08% ROI-118.56% 52W High-3.53% Beta0.91
Dividend TTM- Quick Ratio5.67 Sales past 5Y0.00% Gross Margin- 52W Low284.38% ATR (14)1.47
Dividend Ex-Date- Current Ratio5.67 EPS Y/Y TTM-2.54% Oper. Margin0.00% RSI (14)68.08 Volatility5.58% 6.53%
Employees123 Debt/Eq0.19 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price34.67
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q-23.32% Payout- Rel Volume0.81 Prev Close24.04
Sales Surprise- EPS Surprise-18.92% Sales Q/Q- EarningsOct 30 BMO Avg Volume1.86M Price24.60
SMA209.04% SMA5035.50% SMA20096.25% Trades Volume1,722,336 Change2.33%
Date Action Analyst Rating Change Price Target Change
Feb-20-24Initiated H.C. Wainwright Buy $36
Feb-27-23Upgrade Raymond James Outperform → Strong Buy $16 → $27
Feb-15-23Initiated Oppenheimer Outperform $34
Jan-26-23Initiated Guggenheim Buy $33
Jul-20-22Initiated Chardan Capital Markets Buy $17
Jul-12-22Initiated Raymond James Outperform $15
Oct-12-20Initiated Stifel Buy $29
Oct-12-20Initiated Piper Sandler Overweight $34
Oct-12-20Initiated JP Morgan Overweight $27
Oct-12-20Initiated Jefferies Buy $47
Feb-14-24 04:15PM
Feb-01-24 07:30AM
Jan-26-24 11:01PM
Jan-22-24 10:14PM
Jan-12-24 01:12PM
04:05PM Loading…
Jan-11-24 04:05PM
Jan-05-24 09:02AM
07:30AM
Jan-04-24 10:46PM
04:37PM
12:39PM
Jan-03-24 04:25PM
02:46PM
02:01PM
08:19AM
06:30AM Loading…
06:30AM
Jan-02-24 04:05PM
Nov-13-23 06:59PM
Nov-07-23 07:30AM
Oct-31-23 05:36AM
01:11AM
Oct-30-23 07:30AM
Sep-28-23 07:30AM
Sep-20-23 04:05PM
Sep-15-23 01:52PM
Sep-14-23 01:22PM
Sep-05-23 07:30AM
Aug-28-23 10:22AM
Aug-03-23 07:30AM
Jun-16-23 08:46AM
07:30AM Loading…
Jun-01-23 07:30AM
May-25-23 07:30AM
May-17-23 11:25AM
07:30AM
May-11-23 07:30AM
May-03-23 07:35AM
May-02-23 04:46PM
Mar-23-23 07:30AM
Mar-20-23 07:30AM
Mar-07-23 07:30AM
Mar-02-23 07:30AM
Mar-01-23 09:00AM
Feb-27-23 04:40PM
Feb-05-23 05:03AM
Jan-19-23 08:23AM
Jan-18-23 08:49AM
Jan-10-23 12:00PM
Jan-03-23 07:30AM
Dec-16-22 09:55AM
Dec-09-22 09:55AM
Dec-08-22 08:10AM
Nov-30-22 09:55AM
Nov-03-22 07:30AM
Nov-02-22 07:30AM
Oct-31-22 07:30AM
Oct-12-22 06:45AM
Oct-11-22 04:10PM
Sep-27-22 07:30AM
Sep-12-22 07:00AM
Sep-06-22 04:30PM
07:01AM
07:00AM
Aug-29-22 07:30AM
Aug-10-22 07:30AM
Aug-04-22 07:30AM
Jul-18-22 10:00AM
Jul-12-22 02:54PM
07:30AM
Jul-05-22 07:30AM
Jul-01-22 06:58AM
Jun-03-22 07:30AM
May-16-22 07:30AM
May-02-22 04:05PM
Mar-17-22 08:45AM
Mar-10-22 07:30AM
Mar-03-22 07:30AM
Feb-02-22 01:38PM
Jan-22-22 08:06AM
Jan-18-22 04:18PM
08:00AM
Jan-05-22 07:30AM
Dec-03-21 03:30PM
Dec-02-21 08:30AM
Nov-04-21 07:30AM
Oct-26-21 10:41AM
Oct-13-21 07:45AM
Oct-01-21 10:21AM
07:30AM
Sep-28-21 07:30AM
Sep-27-21 07:30AM
Sep-20-21 07:30AM
Aug-05-21 07:30AM
Jul-26-21 03:00AM
Jun-25-21 07:30AM
Jun-02-21 04:05PM
May-26-21 07:30AM
May-14-21 02:44PM
07:00AM
May-06-21 07:29AM
Apr-27-21 04:35PM
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rhodes Jason PDirectorFeb 23Sale22.70196,9284,470,266920,843Feb 23 06:59 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23Sale22.70159,5423,621,6036,352,562Feb 23 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23Sale22.7037,386848,662920,843Feb 23 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 22Sale22.66119,3602,704,6986,512,104Feb 23 06:58 PM
Rhodes Jason PDirectorFeb 22Sale22.66119,3602,704,6986,512,104Feb 23 06:59 PM
Rhodes Jason PDirectorFeb 21Sale22.57184,5014,164,8176,631,464Feb 23 06:59 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 21Sale22.57184,5014,164,8176,631,464Feb 23 06:58 PM
Rhodes Jason PDirectorFeb 20Sale22.72169,5393,852,6536,815,965Feb 20 06:36 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 20Sale22.72169,5393,852,6536,815,965Feb 20 06:35 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 16Sale23.14162,7073,765,0406,985,504Feb 20 06:35 PM
Rhodes Jason PDirectorFeb 16Sale23.14162,7073,765,0406,985,504Feb 20 06:36 PM
Rhodes Jason PDirectorFeb 15Sale23.89177,9064,249,6007,148,211Feb 20 06:36 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 15Sale23.89177,9064,249,6007,148,211Feb 20 06:35 PM
Farwell WildonChief Medical OfficerFeb 12Sale25.075,493137,710163,503Feb 14 04:27 PM
McNeill JonathanChief Business OfficerJan 26Option Exercise0.7320,00014,600163,618Jan 26 07:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26Option Exercise1.0313,00013,390137,228Jan 26 07:47 PM
McNeill JonathanChief Business OfficerJan 26Sale24.5320,000490,510143,618Jan 26 07:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26Sale24.3413,000316,420124,228Jan 26 07:47 PM
Farwell WildonChief Medical OfficerJan 26Sale25.001002,500168,996Jan 26 07:49 PM
Kersten DirkDirectorJan 09Buy17.501,714,28529,999,9886,416,793Jan 11 04:31 PM
Brumm Joshua TCEO & PresidentJan 04Option Exercise5.16218,5361,127,092803,507Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04Option Exercise1.0322,67423,354199,259Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 04Option Exercise0.732,0091,467145,627Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 04Sale18.51218,5364,045,958584,971Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04Sale18.1342,453769,673156,806Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 04Sale18.042,00936,242143,618Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 03Option Exercise1.0351,18352,718636,154Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03Option Exercise1.0345,32646,686221,911Jan 04 09:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03Option Exercise1.0313,00013,390137,228Jan 04 09:46 PM
McNeill JonathanChief Business OfficerJan 03Option Exercise0.7317,99113,133161,609Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 03Sale19.2851,183986,957584,971Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03Sale18.9845,326860,313176,585Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 03Sale18.7417,991337,062143,618Jan 04 09:47 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03Sale18.8113,000244,530124,228Jan 04 09:46 PM
McNeill JonathanChief Business OfficerJan 02Sale13.1011,900155,890143,618Jan 04 09:47 PM
Scalzo Richard WilliamSee RemarksDec 14Sale12.022,37628,560124,228Dec 14 04:59 PM
Farwell WildonChief Medical OfficerDec 12Sale10.5597810,318169,096Dec 12 05:33 PM
Brumm Joshua TSee RemarksDec 11Sale10.727,58581,311584,971Dec 12 05:33 PM
Farwell WildonChief Medical OfficerDec 11Sale10.721,68818,095170,074Dec 12 05:33 PM
HIGH SUSANNA GATTIChief Operating OfficerDec 11Sale10.721,61617,324187,882Dec 12 05:34 PM
Beskrovnaya OxanaChief Scientific OfficerDec 11Sale10.721,46715,726176,585Dec 12 05:32 PM
Scalzo Richard WilliamSee RemarksDec 11Sale10.721,38014,794126,604Dec 12 05:35 PM
McNeill JonathanChief Business OfficerDec 11Sale10.721,24513,346155,518Dec 12 05:34 PM
Scalzo Richard WilliamSee RemarksDec 06Sale12.011,87222,483127,984Dec 06 06:13 PM
Scalzo Richard WilliamSee RemarksDec 04Sale12.016818,179129,856Dec 06 06:13 PM
HIGH SUSANNA GATTIChief Operating OfficerNov 02Sale7.409,93973,54994,605Nov 02 05:16 PM
Brumm Joshua TSee RemarksSep 18Sale9.4112,032113,221233,679Sep 20 04:47 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 18Sale9.412,67225,144104,544Sep 20 04:48 PM
Beskrovnaya OxanaChief Scientific OfficerSep 18Sale9.411,43613,51384,334Sep 20 04:47 PM
Scalzo Richard WilliamSee RemarksSep 18Sale9.411,29012,13940,795Sep 20 04:49 PM
McNeill JonathanChief Business OfficerSep 18Sale9.411,26111,86660,605Sep 20 04:49 PM
Brumm Joshua TSee RemarksSep 12Sale10.417,67279,866245,711Sep 13 07:50 PM
Farwell WildonChief Medical OfficerSep 12Sale10.411,70717,77089,250Sep 13 07:56 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 12Sale10.411,63517,020107,216Sep 13 07:51 PM
Beskrovnaya OxanaChief Scientific OfficerSep 12Sale10.411,48415,44885,770Sep 13 07:50 PM
Scalzo Richard WilliamSee RemarksSep 12Sale10.411,39714,54342,085Sep 13 07:53 PM
McNeill JonathanChief Business OfficerSep 12Sale10.411,26613,17961,866Sep 13 07:53 PM
Scalzo Richard WilliamSee RemarksJun 15Sale12.0310,000120,30043,482Jun 15 05:46 PM
Scalzo Richard WilliamSee RemarksJun 13Option Exercise1.0340,00041,20093,482Jun 15 05:46 PM
Scalzo Richard WilliamSee RemarksJun 13Sale12.8741,390532,87853,482Jun 15 05:46 PM
Farwell WildonChief Medical OfficerJun 13Sale12.431,69821,10690,957Jun 14 06:40 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 13Sale12.431,62520,199108,851Jun 14 06:40 PM
Beskrovnaya OxanaChief Scientific OfficerJun 13Sale12.431,47518,33487,254Jun 14 06:39 PM
McNeill JonathanSee RemarksJun 13Sale12.431,25915,64963,132Jun 14 06:40 PM
Brumm Joshua TSee RemarksJun 12Option Exercise1.03171,360176,501441,131Jun 12 09:22 PM
Brumm Joshua TSee RemarksJun 12Sale12.61187,7482,367,502253,383Jun 12 09:22 PM
McNeill JonathanSee RemarksJun 12Sale13.001,00013,00064,391Jun 14 06:40 PM
Brumm Joshua TSee RemarksJun 09Option Exercise1.0376,58278,879346,353Jun 12 09:22 PM
Brumm Joshua TSee RemarksJun 09Sale13.3476,5821,021,604269,771Jun 12 09:22 PM
Brumm Joshua TSee RemarksJun 08Option Exercise1.0330,08830,991330,771Jun 12 09:22 PM
Brumm Joshua TSee RemarksJun 08Sale13.2261,000806,690269,771Jun 12 09:22 PM
Farwell WildonChief Medical OfficerMar 14Sale13.337,44199,18992,655Mar 15 05:49 PM
Brumm Joshua TSee RemarksMar 14Sale13.337,31897,549322,483Mar 15 05:49 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 14Sale13.331,55920,781110,476Mar 15 05:50 PM
Beskrovnaya OxanaChief Scientific OfficerMar 14Sale13.331,41618,87588,729Mar 15 05:48 PM
Scalzo Richard WilliamSee RemarksMar 14Sale13.331,31117,47654,872Mar 15 05:51 PM
McNeill JonathanSee RemarksMar 14Sale13.331,20916,11665,391Mar 15 05:50 PM
McNeill JonathanSee RemarksMar 13Sale13.001,00013,00066,600Mar 15 05:50 PM